Omnicell Inc (OMCL)vsTempus AI, Inc. Class A Common Stock (TEM)
OMCL
Omnicell Inc
$34.94
+1.39%
HEALTHCARE · Cap: $1.57B
TEM
Tempus AI, Inc. Class A Common Stock
$46.76
-4.24%
HEALTHCARE · Cap: $8.73B
Smart Verdict
WallStSmart Research — data-driven comparison
Tempus AI, Inc. Class A Common Stock generates 7% more annual revenue ($1.27B vs $1.18B). OMCL leads profitability with a 0.2% profit margin vs -19.3%. OMCL earns a higher WallStSmart Score of 39/100 (F).
OMCL
Hold39
out of 100
Grade: F
TEM
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-13907.4%
Fair Value
$0.27
Current Price
$34.94
$34.67 premium
Intrinsic value data unavailable for TEM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Revenue surging 83.0% year-over-year
Areas to Watch
2.3% revenue growth
Smaller company, higher risk/reward
ROE of 0.2% — below average capital efficiency
0.2% margin — thin
Trading at 16.9x book value
0.0% earnings growth
ROE of -89.5% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : OMCL
The strongest argument for OMCL centers on Price/Book, Debt/Equity.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 83.0% demonstrates continued momentum.
Bear Case : OMCL
The primary concerns for OMCL are Revenue Growth, Market Cap, Return on Equity. A P/E of 861.5x leaves little room for execution misses. Thin 0.2% margins leave little buffer for downturns.
Bear Case : TEM
The primary concerns for TEM are Price/Book, EPS Growth, Return on Equity. Debt-to-equity of 2.63 is elevated, increasing financial risk.
Key Dynamics to Monitor
OMCL profiles as a value stock while TEM is a hypergrowth play — different risk/reward profiles.
TEM is growing revenue faster at 83.0% — sustainability is the question.
OMCL generates stronger free cash flow (20M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
OMCL scores higher overall (39/100 vs 31/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Omnicell Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.
Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?